The role of propranolol for post-exposure chemoprophylaxis of posttraumatic stress disorder and acute stress disorder
Author(s) -
Erin N. Gibbs,
Marshall E. Cates
Publication year - 2013
Publication title -
mental health clinician
Language(s) - English
Resource type - Journals
ISSN - 2168-9709
DOI - 10.9740/mhc.n131052
Subject(s) - propranolol , posttraumatic stress , randomized controlled trial , medicine , chemoprophylaxis , acute stress disorder , placebo , clinical trial , psychiatry , psychology , anesthesia , alternative medicine , pathology
Post traumatic stress disorder may be due to excessive adrenergic activation immediately following trauma leading to over-consolidation of traumatic memories. Based on this premise, propranolol has been studied as a means of post-exposure prophylaxis of posttraumatic stress disorder and acute stress disorder. Published trials include a retrospective chart review, a prospective cohort study, and a number of randomized clinical trials. Current data suggest ineffectiveness of propranolol for this indication, but larger, randomized, placebo-controlled trials that include more diverse types of traumas are needed in order to provide more definitive evidence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom